NL-OMON42668已完成不适用
A RANDOMIZED DOUBLE-BLIND TRIAL, USING A SINGLE-BLIND RUN-IN TO ASSESS WITHDRAWAL SYMPTOMS AFTER PROLONGED TREATMENT WITH CANNABIDIOL (GWP42003-P) - Cannabidiol (GWP42003-P) withdrawal trial
PRA International EDS0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- healthy male/ female subjects
- •- 18-45 yrs, inclusive
- •- BMI: 18.0-28.0 kg/m2, inclusive
排除标准
- •Suffering from hepatitis B, hepatitis C, cancer or HIV/AIDS. In case of participation in another drug study within 90 days before the start of this study or being a blood donor within 60 days from the start of the study. In case of donating more than 1.5 liters of blood (for men) / 1.0 liters of blood (for women) in the 10 months prior the start of this study.
研究者
相似试验
进行中（未招募）
不适用
A DOUBLE-BLIND RANDOMIZED PLACEBO-CONTROLLED TRIAL OF THE TIME TO ONSET OF MEANINGFUL PAIN RELIEF IN SUBJECTS WITH POSTHERPETIC NEURALGIA (PHN) TREATED WITH PREGABALIN (150 - 600 MG/DAY FLEXIBLE OPTIMIZED DOSE OR 300 MG/DAY FIXED DOSE OR PLACEBOMedDRA version: 6.1Level: HLTClassification code 10034607Postherpetic NeuralgiaEUCTR2004-002563-24-ITPFIZER
已完成
不适用
COMPARISON OF THE CLINICAL EFFICACY OF COLD-CHAIN AND OUTSIDE COLD-CHAIN OXYTOCIN IN DECREASING POSTPARTUM BLOOD LOSS IN WARRI, DELTA STATE, NIGERIA.Circulatory SystemPregnancy and ChildbirthPACTR202203635007430OKWUCHUKWU ONYEOWUZONI140
进行中（未招募）
不适用
A RANDOMIZED, BLINDED, CROSSOVER TRIAL OF A SINGLE DOSE OF ORAL L-DOPS 300 MG IN AN ENVIRONMENTAL EXPOSURE UNIT IN SUBJECTS WITH SEASONAL ALLERGIC RHINITIS - L-DOPS in SARseasonal allergic rhinitisMedDRA version: 7.0Level: LLTClassification code 10039776EUCTR2004-002708-13-DESynergia Pharma, Inc.
进行中（未招募）
不适用
DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED TRIAL TO TEST THE EFFICACY, SAFETY AND TOLERABILITY OF LITHIUM IN MULTIPLE SYSTEM ATROPHY - Lithium in MSAEUCTR2009-016377-15-ITIVERSITA` DEGLI STUDI DI NAPOLI FEDERICO II
尚未招募
不适用
Bridging Trial of Bivalent Killed Oral Cholera Vaccine in EthiopiaCholeraPACTR201202000354245International Vaccine Institute216